Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.728 INR | -0,59% | -2,00% | -10,19% |
Omzet 2024 * | 56,49 mld. 678 mln. 633 mln. | Omzet 2025 * | 63,2 mld. 758 mln. 709 mln. | Marktkapitalisatie | 285 mld. 3,41 mld. 3,19 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 8,48 mld. 102 mln. 95,09 mln. | Nettowinst (verlies) 2025 * | 11,02 mld. 132 mln. 124 mln. | EV/omzet 2024 * | 4,55 x |
Nettoliquiditeiten 2024 * | 27,5 mld. 330 mln. 308 mln. | Nettoliquiditeiten 2025 * | 31,55 mld. 378 mln. 354 mln. | EV/omzet 2025 * | 4,01 x |
K/w-verhouding 2024 * |
33,5
x | K/w-verhouding 2025 * |
25,8
x | Werknemers | 4.585 |
Dividendrendement 2024 * |
0,1% | Dividendrendement 2025 * |
0,2% | Vrij verhandelbaar | 38,38% |
Recentste transcriptie over Gland Pharma Limited
1 dag | -0,59% | ||
1 week | -2,00% | ||
Lopende maand | -6,34% | ||
1 maand | -3,52% | ||
3 maanden | -8,99% | ||
6 maanden | +12,41% | ||
Lopend jaar | -10,19% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Srinivas Sadu
CEO | Chief Executive Officer | 55 | 01-01-00 |
Director of Finance/CFO | - | 30-09-19 | |
C. S. Venkatesan
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-98 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fang Yao
BRD | Director/Board Member | 54 | 10-03-22 |
Srinivas Sadu
CEO | Chief Executive Officer | 55 | 01-01-00 |
Yiu Kwan Lau
CHM | Chairman | 69 | 10-06-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1.728 | -0,59% | 166 537 |
25-04-24 | 1.739 | -1,03% | 74 251 |
24-04-24 | 1.757 | -1,41% | 89 617 |
23-04-24 | 1.782 | +0,28% | 76 362 |
22-04-24 | 1.777 | +0,75% | 86 990 |
uitgestelde koers NSE India S.E., 26 april 2024 om 13:43 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,19% | 3,44 mld. | |
+25,83% | 653 mld. | |
+27,00% | 556 mld. | |
-6,76% | 354 mld. | |
+20,34% | 331 mld. | |
+3,00% | 296 mld. | |
+13,09% | 233 mld. | |
+5,46% | 201 mld. | |
-9,61% | 193 mld. | |
-6,26% | 144 mld. |